PMC:7048180 / 8006-8207
Annnotations
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T30","span":{"begin":148,"end":156},"obj":"Body_part"}],"attributes":[{"id":"A30","pred":"fma_id","subj":"T30","obj":"http://purl.org/sig/ont/fma/fma62871"}],"text":" did not show evident binding to 2019-nCoV RBD. To confirm this result, we further measured the binding kinetics using BLI. An irrelevant anti-CD40 antibody was used as a negative control. Similarly, t"}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T50","span":{"begin":169,"end":170},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":" did not show evident binding to 2019-nCoV RBD. To confirm this result, we further measured the binding kinetics using BLI. An irrelevant anti-CD40 antibody was used as a negative control. Similarly, t"}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T48","span":{"begin":48,"end":123},"obj":"Sentence"},{"id":"T49","span":{"begin":124,"end":188},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":" did not show evident binding to 2019-nCoV RBD. To confirm this result, we further measured the binding kinetics using BLI. An irrelevant anti-CD40 antibody was used as a negative control. Similarly, t"}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"286","span":{"begin":143,"end":147},"obj":"Gene"},{"id":"289","span":{"begin":33,"end":42},"obj":"Species"}],"attributes":[{"id":"A286","pred":"tao:has_database_id","subj":"286","obj":"Gene:958"},{"id":"A289","pred":"tao:has_database_id","subj":"289","obj":"Tax:2697049"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" did not show evident binding to 2019-nCoV RBD. To confirm this result, we further measured the binding kinetics using BLI. An irrelevant anti-CD40 antibody was used as a negative control. Similarly, t"}